NCT04569734 - The ICE WATCHMAN Trial | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions

Left Atrial Appendage Closure With WATCHMAN Device Utilizing an Intra-procedural ICE Probe

Interventions

PROCEDURE

WATCHMAN device implant procedure utilizing ICE probe

The study will be a prospective, non-randomized multicenter registry of 100 patients undergoing LAA closure with the WATCHMAN device (possibly with WATCHMAN FLX when approved) utilizing an intra-procedural ICE probe under moderate sedation.

Trial Locations (2)

55905

Mayo Clinic Rochester, Rochester

98404

Pacific Heart Institute, Santa Monica